Old CIC Events
21/02/2019
An epigenetic journey into the origin and evolution of B cell tumors
José Ignacio Martín Subero — IDIBAPS, Universidad de Barcelona [Barcelona]
14/02/2019
Clonal evolution of pre-malignant B-cells in the absence of AID
Guillermo Rodríguez-Hernández — Centro de Investigación del Cáncer, CIC-IBMCC, lab.13
12/02/2019
Role of microRNAs in B cell differentiation and neoplastic transformation.
Virginia García de Yébenes Mena — Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid
07/02/2019
Enhancer defects in acute myeloid leukemia (AML): The Evil-side of gene regulation
Ruud Delwel — Erasmus MC hospital [Rotterdam, Netherlands]
31/01/2019
Nuevas dianas terapéuticas y papel de la medicina de precisión en inmunooncología
Víctor Moreno — Director, Clinical Research Phase 1 Trials Unit START MADRID-FJD, Hospital Fundación Jiménez Díaz
24/01/2019
Desarrollo de nuevas estrategias para diagnóstico y clasificación de inmunodeficiencias predominantemente de anticuerpos
Elena Blanco Álvarez — Centro de Investigación del Cáncer (CIC-IBMCC), lab. 11 Salamanca
21/01/2019
Secreted factors and their role in Regeneration: Discovery and Therapeutic Applications
Pilar Ruiz Lozano — Regencor, Inc. y del Departamento de Pediatría (Cardiología) de la Stanford University School of Medicine, California (USA)
17/01/2019
Chromatin Conformation in Development and Disease
Juan Manuel Vaquerizas — Max Planck Institute for Molecular Biomedicine [Münster, Germany]
15/01/2019
Short-term activation of the Jun-N terminal Kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis
Noelia Pinal Seoane — Centro de Biología Molecular "Severo Ochoa" (CBMSO) de Madrid
10/01/2019
Identification of genetic and molecular determinants associated with cardiotoxicity by anthracyclines and taxanes
Aurora Gómez Vecino — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca

